Yifan Pharmaceutical Co. Ltd. A | Ownership
Companies that own Yifan Pharmaceutical Co. Ltd. A
Goldstate Capital Fund Management Co., Ltd.
21,235,294
3%
21,235,294
3.03%
08/27/2018
E Fund Management Co., Ltd.
14,705,882
2.08%
13,568,699
0.19%
08/27/2018
Qian Hai Life Insurance Co., Ltd.
11,299,468
1.6%
11,299,468
0.38%
09/30/2017
Guotai Asset Management Co., Ltd.
11,233,537
1.59%
8,625,473
0.32%
12/31/2017
Essence Fund Co., Ltd.
11,176,470
1.58%
11,176,470
0.93%
08/27/2018
Bosera Asset Management Co., Ltd.
10,499,825
1.48%
10,499,825
0.16%
09/30/2017
ABC-CA Fund Management Co., Ltd.
8,764,712
1.24%
196,879
1.05%
12/31/2017
China Southern Asset Management Co., Ltd.
6,922,669
0.98%
3,813,800
0.12%
12/31/2017
Sichuan Trust Co., Ltd.
3,029,414
0.43%
3,029,414
2.62%
08/27/2018
China Universal Asset Management Co., Ltd.
2,832,980
0.4%
1,751,380
0.05%
12/31/2017
| Address |
No. 50 Qinshan
Hangzhou Zhejiang 311300
China
|
|
Employees
|
- |
| Website |
http://www.xinfupharm.com |
| Updated |
07/08/2019 |
| Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. It focuses on pharmaceutical products, raw materials, and polymer materials. The pharmaceutical products include antibiotics, cardiovascular and cerebrovascular, skin, gynecology, pediatric, blood tumor, and treatment of large infusion. |
